Sutent scores against Steve Jobs-type cancer

Pfizer's Sutent delayed the worsening of the type of pancreatic cancer that afflicted Apple Chief Executive Steve Jobs by more than five months longer than a placebo, according to data from a clinical trial. Report

Suggested Articles

With AbbVie's two most recent launches outperforming expectations, investors could be looking at a steal with an Allergan merger looming.

Investors are clamoring for a CVR created in the BMS-Celgene deal, but it will only pay off if the FDA approves three hot pipeline projects.

Muzammil Mansuri, Sanofi’s EVP of strategy and business development since February 2016, is retiring at the end of November.